The Jintronix Interactive System for Upper Extremity Rehabilitation Training Post Stroke
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03759145 |
|
Recruitment Status :
Completed
First Posted : November 29, 2018
Last Update Posted : November 30, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Stroke | Other: Exergame Other: usual care | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 18 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | The Jintronix Interactive System for Upper Extremity Rehabilitation Training Post Stroke: A Pilot Study |
| Actual Study Start Date : | March 2014 |
| Actual Primary Completion Date : | January 2016 |
| Actual Study Completion Date : | January 2016 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention arm, usual rehabilitation + Jintronix exergame
On top of the usual out-patient rehabilitation sessions planned for the participant, participants attend sessions to use the Jintronix system for up 30 minutes up to 3 times per week
|
Other: Exergame
Participants use exergame with the therapist in the rehabilitation center. Several games are available, the therapist adjusts the choice of game and level of difficulty according to the participant's abilities and interests. |
|
Control group
Participants continue their prescribed rehabilitation sessions
|
Other: usual care
participants continued their planned rehabilitation sessions |
- number of sessions (feasibility) [ Time Frame: 4 week period ]number of sessions the participant used the system during the study period
- duration of sessions [ Time Frame: 4 week period (ongoing) ]the average duration of sessions (minutes)
- time spent by therapist assisting the participant [ Time Frame: 4 week period (ongoing) ]time during the sessions that the therapist spent assisting the participant (minutes)
- time spent on each exergame [ Time Frame: 4 week period (ongoing) ]the time spent on each exergame (minutes)
- adverse event (counts) [ Time Frame: 4 week period (ongoing) ]occurrence of adverse events such as falls, motion sickness, dizziness and headaches
- adverse event (borg exertion scale, self-reported scale 6-20, (Borg Exertion Scale scored from 6-20, no exertion to maximal exertion) [ Time Frame: 4 week period (ongoing) ]exertion after playing the exergame reported using the Borg Exertion Scale
- adverse event (pain self reported on visual analog scale 0-10) [ Time Frame: 4 week period (ongoing) ]pain after playing the exergame reported using visual analog scale 0-10, 0 is no pain, 10 is the worse pain imaginable.
- Stroke-specific measure of quality of life - Stroke Impact Scale [ Time Frame: 4 week period (per-post) ]Stroke Impact Scale is a questionnaire of the impact that the stroke is having on function, mood, emotional status, total score 0-100, with with higher scores indicating better self-reported health.
- upper limb function assessed using the Motor Activity Log [ Time Frame: 4 week period (per-post) ]The Motor Activity Log is a questionnaire that the participant completes reporting how much the impaired upper limb is used for various daily tasks, each task is scored from 0-5 (ordinal scale, 0=do not use arm - 6=use as much as before), total score is mean of the scores.
- upper limb function assessed using the Box and Block test [ Time Frame: 4 week period (per-post) ]upper limb function is assessed using the box and block test where participants are timed while picking up and placing wooden cubes
- upper limb motor control assessed using the Fugl-Meyer Assessment-upper extremity [ Time Frame: 4 week period (per-post) ]Upper limb motor control is assessed using a valid and reliable outcome, measure consisting of tasks to be performed by the participant, scores between 0-66, higher scores indicating better motor control.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- having had an ischemic or hemorrhagic stroke for the first time;
- having residual mild to moderate UE impairment (score 3-6 on the Chedoke-McMaster arm component, as long as exergames can be played);
- being in subacute stage (within 6 months post-stroke);
- receiving usual out-patient rehabilitation services at one of the two selected rehabilitation sites, located in the greater Montreal area in Canada.
Exclusion Criteria:
- being medically unstable;
- having severe cognitive or communication deficits;
- having visual impairments limiting use of the exergame;
- having any medical contraindication for shoulder movements;
- having severe balance deficits limiting sitting safely independently;
- having previous upper limb impairment limiting potential recovery;
- having any other impairment that limited use of the exergame.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03759145
| Canada, Quebec | |
| Université de Montréal | |
| Montréal, Quebec, Canada, H3N 1X7 | |
| Responsible Party: | Dahlia Kairy, Associate professor, Université de Montréal |
| ClinicalTrials.gov Identifier: | NCT03759145 |
| Other Study ID Numbers: |
CRIR-795-0113 |
| First Posted: | November 29, 2018 Key Record Dates |
| Last Update Posted: | November 30, 2018 |
| Last Verified: | November 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
virtual reality exergame stroke rehabilitation |
|
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |

